Table 1.
Baseline characteristics of patients.
| Baseline Characteristic | N = 107 |
|---|---|
| Age (years) | 59 ± 13 |
| Male | 86 (80) |
| Ethnicity | |
| Europid | 79 (74) |
| South Asian | 13 (12) |
| Eastern Mediterranean | 5 (5) |
| Arabic | 4 (4) |
| Chinese | 4 (4) |
| South American | 1 (1) |
| Polynesian | 1 (1) |
| Hypertension | 51 (48) |
| Smoking | 20 (19) |
| Diabetes mellitus | 20 (19) |
| Family history | 34 (32) |
| Dyslipidaemia | 43 (40) |
| Statin on admission | 19 (18) |
| New IFG | 42 (39) |
| Waist Circumference (cm) | |
| Males | 101.6 ± 12.8 |
| Females | 100.4 ± 18.3 |
| Height (cm) | |
| Males | 1.70 ± 0.11 |
| Females | 1.57 ± 0.09 |
| Weight (kg) | |
| Males | 85.0 ± 16.2 |
| Females | 72.2 ± 19.9 |
| BMI (kg/m2) | |
| Males | 29.8 ± 8.5 |
| Female | 29.4 ± 8.3 |
| Waist: Hip | 1.08 ± 0.97 |
| Systolic BP | 112.8 ± 15.1 |
| Diastolic BP | 66.9 ± 9.5 |
| Discharge Medications | |
| Aspirin | 91 (85) |
| Statin | 93 (87) |
| Fibrate | 2 (2) |
| Ezetimibe | 3 (3) |
| Beta blocker | 90 (84) |
| ACE-Inhibitor | 76 (71) |
| ATRA | 9 (8) |
| Clopidogrel | 92 (86) |
Data are presented as mean ± SD or n (%); BMI: body mass index; IFG: impaired fasting glucose.